GB8817743D0
(en)
|
1988-07-26 |
1988-09-01 |
Fujisawa Pharmaceutical Co |
Fr901228 substance & preparation thereof
|
GB9001318D0
(en)
*
|
1990-01-19 |
1990-03-21 |
Fujisawa Pharmaceutical Co |
Wb968 substances and preparation thereof
|
JPH0764872A
(ja)
|
1993-08-26 |
1995-03-10 |
Fujitsu Ten Ltd |
データ記憶制御装置
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
US6030961A
(en)
|
1997-03-11 |
2000-02-29 |
Bar-Ilan Research & Development Co., Ltd. |
Oxyalkylene phosphate compounds and uses thereof
|
EP1010705A4
(en)
|
1997-09-02 |
2004-09-15 |
Sumitomo Pharma |
NEW CYCLIC TETRAPEPTIDE DERIVATIVES AND THEIR MEDICAL USE
|
JPH11335375A
(ja)
|
1998-05-20 |
1999-12-07 |
Mitsui Chem Inc |
ヒストン脱アセチル化酵素阻害作用を有するベンズアミド誘導体
|
US20070148228A1
(en)
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
WO2001018171A2
(en)
|
1999-09-08 |
2001-03-15 |
Sloan-Kettering Institute For Cancer Research |
Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
|
US6828302B1
(en)
|
1999-12-08 |
2004-12-07 |
Xcyte Therapies, Inc. |
Therapeutic uses of depsipeptides and congeners thereof
|
ATE470447T1
(de)
|
1999-12-08 |
2010-06-15 |
Cyclacel Pharmaceuticals Inc |
Depsipetid und kongenere davon für den einsatz als immunsuppressiva zur vorbeugung und behandlung von abstossreaktionen infolge einer transplantation und zur induktion des apoptosis in aktivierten cd4 oder cd8 t-zellen
|
CA2317003A1
(en)
|
2000-02-28 |
2001-08-28 |
Hidenori Nakajima |
Gene expression potentiator
|
JP2001348340A
(ja)
|
2000-06-07 |
2001-12-18 |
Yamanouchi Pharmaceut Co Ltd |
ヒストン脱アセチル化酵素阻害剤
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
ES2321584T3
(es)
|
2000-07-17 |
2009-06-09 |
Astellas Pharma Inc. |
Fk228 reducido y su uso.
|
WO2002015921A2
(en)
|
2000-08-18 |
2002-02-28 |
The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
|
WO2002020817A1
(en)
*
|
2000-09-01 |
2002-03-14 |
Fujisawa Pharmaceutical Co., Ltd. |
A method of producing fr901228
|
WO2002055017A2
(en)
|
2000-11-21 |
2002-07-18 |
Wake Forest University |
Method of treating autoimmune diseases
|
JP2005507231A
(ja)
|
2001-01-10 |
2005-03-17 |
アメリカ合衆国 |
甲状腺新生物の診断および治療におけるヒストン脱アセチル酵素阻害剤
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
DE60227658D1
(de)
|
2001-05-02 |
2008-08-28 |
Univ California |
Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
|
RU2298414C2
(ru)
|
2001-08-21 |
2007-05-10 |
Астеллас Фарма Инк. |
Медицинское применение ингибитора гистоновой дезацетилазы и способ оценки его противоопухолевого действия
|
US20040259772A1
(en)
|
2001-08-24 |
2004-12-23 |
Antonio Fojo |
Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
|
EP1293205A1
(en)
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
US6706686B2
(en)
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
WO2003035843A2
(en)
|
2001-10-25 |
2003-05-01 |
Buck Institute For Age Research |
Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
|
WO2003053468A1
(en)
|
2001-12-21 |
2003-07-03 |
Universite Libre De Bruxelles |
Method for obtaining the elimination of integrated and functional viruses from infected mammal cells
|
US20030134423A1
(en)
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
JP2005525345A
(ja)
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Trx媒介性疾患を処置する方法
|
AU2003211576A1
(en)
|
2002-02-20 |
2003-09-09 |
Sueharu Horinouchi |
Histone deacetylase inhibitors and process for producing the same
|
RU2320331C2
(ru)
|
2002-03-04 |
2008-03-27 |
МЕРК ЭйчДиЭйСи Рисерч, ЛЛС. |
Способ индукции конечной дифференцировки
|
AU2003226014A1
(en)
|
2002-03-28 |
2003-10-13 |
Brigham And Women's Hospital, Inc. |
Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
|
CA2481466A1
(en)
|
2002-04-05 |
2003-10-16 |
Yoshinori Naoe |
Depsipeptide for therapy of kidney cancer
|
US20040018968A1
(en)
|
2002-04-15 |
2004-01-29 |
George Sgouros |
Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer
|
US6809118B2
(en)
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
US20040002447A1
(en)
|
2002-06-04 |
2004-01-01 |
Regents Of The University Of California |
Induction of insulin expression
|
US20050065596A1
(en)
|
2002-07-24 |
2005-03-24 |
Xufan Tseng |
Stents capable of controllably releasing histone deacetylase inhibitors
|
DE60332367D1
(de)
|
2002-08-20 |
2010-06-10 |
Astellas Pharma Inc |
Hemmer des abbaus der extrazellulären matrix von arthrodia-knorpel
|
JP3987909B2
(ja)
|
2002-08-30 |
2007-10-10 |
アステラス製薬株式会社 |
新規なデプシペプチド化合物
|
CN1681505A
(zh)
|
2002-09-13 |
2005-10-12 |
弗吉尼亚州立大学 |
用于治疗白血病的а ) N-{ 5-[ 4-( 4-甲基-哌嗪-1-基-甲基)-苯甲酰氨基]-2-甲基苯基}-4-( 3-吡啶基 ) -2-嘧啶-胺和b )组蛋白脱乙酰基酶抑制剂的组合
|
SE0300098D0
(sv)
|
2003-01-15 |
2003-01-15 |
Forskarpatent I Syd Ab |
Use of cyclin D1 inhibitors
|
US20050222013A1
(en)
|
2003-01-16 |
2005-10-06 |
Georgetown University |
Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
|
JPWO2004074478A1
(ja)
|
2003-02-19 |
2006-06-01 |
アステラス製薬株式会社 |
ヒストンデアセチラーゼ阻害剤の抗腫瘍効果の予測方法
|
US7988957B2
(en)
|
2003-04-25 |
2011-08-02 |
Genesis Healthcare Corp. |
Gene introduction efficiency enhancer
|
US20040213826A1
(en)
|
2003-04-28 |
2004-10-28 |
Marx Steven O. |
Medical devices and methods for inhibiting proliferation of smooth muscle cells
|
EP1491188A1
(en)
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
ES2341771T3
(es)
|
2003-06-27 |
2010-06-28 |
Astellas Pharma Inc. |
Agente terapeutico contra el sarcoma de tejidos blandos.
|
UA84156C2
(ru)
|
2003-07-23 |
2008-09-25 |
Байер Фармасьютикалс Корпорейшн |
Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
|
ATE462426T1
(de)
|
2003-08-26 |
2010-04-15 |
Merck Hdac Res Llc |
Verwendung von saha zur behandlung von mesotheliom
|
CN102349927A
(zh)
|
2003-08-29 |
2012-02-15 |
Hdac默克研究有限责任公司 |
联合治疗癌症的方法
|
US20060074124A1
(en)
|
2003-09-12 |
2006-04-06 |
Andrew Napper |
Methods of treating a disorder
|
BRPI0414568A
(pt)
|
2003-09-18 |
2006-11-07 |
Combinatorx Inc |
combinações de drogas para o tratamento de neoplasmas
|
EP2263694B1
(en)
|
2003-09-25 |
2013-06-12 |
Astellas Pharma Inc. |
Antitumor agent comprising the histone deacetylase inhibitor FK228 and the topoisomerase II inhibitor doxorubicin
|
US20070110719A1
(en)
|
2003-11-14 |
2007-05-17 |
Holm Per S |
Novel use of adenoviruses and nucleic acids that code for said viruses
|
JP2007511212A
(ja)
|
2003-11-14 |
2007-05-10 |
ホルム,ペル・ゾンネ |
新規アデノウイルス、それをコードする核酸及びその使用
|
WO2005053609A2
(en)
|
2003-11-26 |
2005-06-16 |
Guilford Pharmaceuticals Inc. |
Methods of nad+-dependent deacetylase inhibitors
|
EP1713460A2
(en)
|
2003-12-10 |
2006-10-25 |
Wisconsin Alumni Research Foundation |
Fk228 analogs and their use as hdac-inhibitors
|
US7951780B2
(en)
|
2004-02-25 |
2011-05-31 |
Astellas Pharma Inc. |
Antitumor agent
|
US20050187148A1
(en)
|
2004-02-25 |
2005-08-25 |
Yoshinori Naoe |
Antitumor agent
|
AU2005218769B8
(en)
|
2004-02-27 |
2012-04-12 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Pharmacodynamic assays using flow cytometry
|
US20060228404A1
(en)
|
2004-03-04 |
2006-10-12 |
Anderson Daniel G |
Compositions and methods for treatment of hypertrophic tissues
|
GB0405349D0
(en)
|
2004-03-10 |
2004-04-21 |
Univ Birmingham |
Cancer therapy and medicaments therefor
|
SI1591109T1
(sl)
|
2004-04-30 |
2008-10-31 |
Topotarget Germany Ag |
Formulacija, ki obsega inhibitor histon-deacetilaze in izkazuje dvofazno sproščanje
|
ITMI20040876A1
(it)
|
2004-04-30 |
2004-07-30 |
Univ Degli Studi Milano |
Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
|
US20050261174A1
(en)
|
2004-05-20 |
2005-11-24 |
Paul Lewer |
Insecticidal activity of a cyclic peptide
|
WO2005117930A2
(en)
|
2004-06-04 |
2005-12-15 |
Sloan-Kettering Institute For Cancer Research |
Use of thioredoxin measurements for diagnostics and treatments
|
WO2005123089A2
(en)
|
2004-06-10 |
2005-12-29 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
US20060018921A1
(en)
|
2004-07-16 |
2006-01-26 |
Baylor College Of Medicine |
Histone deacetylase inhibitors and cognitive applications
|
ES2368930T3
(es)
|
2004-09-06 |
2011-11-23 |
Bayer Pharma Aktiengesellschaft |
Pirazolopirimidinas como inhibidores de proteína cinasa b (akt).
|
JP2008520682A
(ja)
|
2004-11-17 |
2008-06-19 |
ザ ユニヴァーシティー オヴ シカゴ |
ヒストンデアセチラーゼ阻害剤およびその使用方法
|
WO2006060382A2
(en)
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
WO2006060429A2
(en)
|
2004-12-03 |
2006-06-08 |
Novartis Ag |
Identification of variants in histone deacetylase 1 (hdac1) to predict drug response
|
US20060128660A1
(en)
|
2004-12-10 |
2006-06-15 |
Wisconsin Alumni Research Foundation |
FK228 analogs and methods of making and using the same
|
WO2006105440A2
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20060229237A1
(en)
|
2005-04-07 |
2006-10-12 |
Yih-Lin Chung |
Treatment of gastrointestinal distress
|
GB0511266D0
(en)
|
2005-06-02 |
2005-07-13 |
Trust |
Chemical compounds
|
EP1743654A1
(en)
|
2005-07-15 |
2007-01-17 |
TopoTarget Germany AG |
Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases
|
CA2618439A1
(en)
|
2005-08-12 |
2007-02-22 |
Astellas Pharma Inc. |
Technique for stabilization of yw753 reparation
|
US7439695B2
(en)
*
|
2005-08-19 |
2008-10-21 |
Komatsu America Corp. |
Mechanical braking system for use on a vehicle having an electric propulsion system and automatic retard speed regulation
|
WO2007040522A1
(en)
*
|
2005-09-30 |
2007-04-12 |
The Ohio State Research Foundation |
Antitumor agents
|
EP1957673A2
(en)
|
2005-11-10 |
2008-08-20 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment
|
EP1965824A4
(en)
|
2005-11-18 |
2011-10-19 |
Gloucester Pharmaceuticals Inc |
METABOLITENE DERIVATIVES OF HDAC INHIBITOR FK228
|
GB0524316D0
(en)
|
2005-11-29 |
2006-01-04 |
Medical Res Council |
Tumour necrosis factor-related apoptosis-inducing ligands (TRAILs)
|
CA2632903C
(en)
|
2005-12-02 |
2015-11-24 |
Vianova Labs, Inc. |
Treatment of cancer and other diseases
|
WO2007084775A2
(en)
|
2006-01-20 |
2007-07-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for modulation of suppressor t cell activation
|
US9539303B2
(en)
|
2006-04-24 |
2017-01-10 |
Celgene Corporation |
Treatment of Ras-expressing tumors
|
US8957027B2
(en)
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
US20070292512A1
(en)
|
2006-06-09 |
2007-12-20 |
Merrion Research Ii Limited |
Solid Oral Dosage Form Containing an Enhancer
|
EP2046293A2
(en)
|
2006-07-10 |
2009-04-15 |
Medigene AG |
Use of a cationic colloidal preparation for the diagnosis and treatment of ocular diseases
|
JP5230625B2
(ja)
|
2006-09-15 |
2013-07-10 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
クラス−i特異的ヒストンデアセチラーゼ阻害剤とプロテアソーム阻害剤の組み合わせ
|
AU2007323215B2
(en)
|
2006-11-22 |
2012-07-19 |
Karus Therapeutics Limited |
Depsipeptides and their therapeutic use
|
GB0623388D0
(en)
|
2006-11-23 |
2007-01-03 |
Univ Southampton |
Chemical compounds
|
CN101687010A
(zh)
|
2006-12-29 |
2010-03-31 |
格洛斯特制药公司 |
制备Romidepsin
|
MX2009007777A
(es)
|
2007-01-23 |
2009-12-16 |
Gloucester Pharmaceuticals Inc |
Terapia de combinacion que comprende romidepsina y bortezomib.
|
WO2008127659A2
(en)
|
2007-04-13 |
2008-10-23 |
University Of Texas Southwestern Medical Center |
Combination therapy for cancer
|
US7939546B2
(en)
|
2007-10-12 |
2011-05-10 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
WO2009067543A2
(en)
|
2007-11-19 |
2009-05-28 |
The Regents Of The University Of Colorado |
Treatment of histone deacetylase mediated disorders
|
WO2009067453A1
(en)
|
2007-11-19 |
2009-05-28 |
Syndax Pharmaceuticals, Inc. |
Combinations of hdac inhibitors and proteasome inhibitors
|
WO2009108755A2
(en)
|
2008-02-27 |
2009-09-03 |
Wyeth |
Pharmaceutical combinations for the treatment of cancer
|
US20090270497A1
(en)
|
2008-04-24 |
2009-10-29 |
Pharmacyclics, Inc. |
Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
|
WO2009137378A2
(en)
|
2008-05-05 |
2009-11-12 |
Schering Corporation |
Sequential administration of chemotherapeutic agents for treatment of cancer
|
US8637554B2
(en)
|
2008-05-07 |
2014-01-28 |
The Trustees Of The University Of Pennsylvania |
Methods for treating thyroid cancer
|
WO2009155659A1
(en)
|
2008-06-27 |
2009-12-30 |
The University Of Queensland |
Combination therapy
|
US8623853B2
(en)
|
2008-07-23 |
2014-01-07 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancers characterized by chromosomal rearrangement of the NUT gene
|
EP2309854A4
(en)
|
2008-07-30 |
2012-06-06 |
Gloucester Pharmaceuticals Inc |
ACCELERATED THERAPY:
|